Cargando…

The cost-effectiveness of adjunctive corticosteroids for patients with septic shock

Objective: To determine whether hydrocortisone is a cost-effective treatment for patients with septic shock. Design: Data linkage-based cost-effectiveness analysis. Setting: New South Wales and Queensland intensive care units. Participants and intervention: Patients with septic shock randomly assign...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thompson, Kelly J., Taylor, Colman B., Venkatesh, Balasubramanian, Cohen, Jeremy, Hammond, Naomi E., Jan, Stephen, Li, Qiang, Myburgh, John, Rajbhandari, Dorrilyn, Saxena, Manoj, Kumar, Ashwani, Finfer, Simon R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692584/ https://www.ncbi.nlm.nih.gov/pubmed/32900325 http://dx.doi.org/10.1016/S1441-2772(23)00386-1

Ejemplares similares

Sex differences in response to adjunctive corticosteroid treatment for patients with septic shock
por: Thompson, Kelly, et al.
Publicado: (2021)

Does asymmetry in patient recruitment in large critical care trials follow the Pareto principle?
por: Ramanan, Mahesh, et al.
Publicado: (2020)

Clinician preferences for prescription of corticosteroids in patients with septic shock: an international survey
por: Hammond, Naomi E., et al.
Publicado: (2023)

Effects of low-dose hydrocortisone and hydrocortisone plus fludrocortisone in adults with septic shock: a protocol for a systematic review and meta-analysis of individual participant data
por: Annane, Djillali, et al.
Publicado: (2020)

An evaluation of factors that may influence clinicians’ decisions not to enroll eligible patients into randomized trials in critical care
por: Ramanan, Mahesh, et al.
Publicado: (2021)

Sepsis-coded hospitalisations and associated costs in Australia: a retrospective analysis
por: Kumar, Ashwani, et al.
Publicado: (2023)

Outcomes following severe septic shock in a cohort of Aboriginal and Torres Strait Islander people: a nested cohort study from the ADRENAL trial
por: Donaldson, Lachlan H., et al.
Publicado: (2023)

Challenges in operationalising clinical trials in India during the COVID-19 pandemic
por: Bassi, Abhinav, et al.
Publicado: (2022)

Injury in China: a systematic review of injury surveillance studies conducted in Chinese hospital emergency departments
por: Fitzharris, Michael, et al.
Publicado: (2011)

Potential for overuse of corticosteroids and vasopressin in septic shock
por: Hsu, Joe L, et al.
Publicado: (2012)

Long-Term Survival and Dialysis Dependency Following Acute Kidney Injury in Intensive Care: Extended Follow-up of a Randomized Controlled Trial
por: Gallagher, Martin, et al.
Publicado: (2014)

Impact of corticosteroid administration in septic shock on glycemic variability
por: Mirea, L, et al.
Publicado: (2014)

The Role of ACTH and Corticosteroids for Sepsis and Septic Shock: An Update
por: Annane, Djillali
Publicado: (2016)

Timing of vasoactive agents and corticosteroid initiation in septic shock
por: Ammar, Mahmoud A., et al.
Publicado: (2022)

The Plasma-Lyte 148 versus Saline (PLUS) statistical analysis plan: a multicentre, randomised controlled trial of the effect of intensive care fluid therapy on mortality
por: Billot, Laurent, et al.
Publicado: (2023)

Corticosteroids as adjunctive therapy with antibiotics in the treatment of children with septic arthritis: a meta-analysis
por: Qin, Ya-fei, et al.
Publicado: (2018)

Final approval for corticosteroids in severe CAP? For sure, in septic shock
por: Martin-Loeches, Ignacio, et al.
Publicado: (2023)

Hydroxychloroquine plus personal protective equipment versus standard personal protective equipment alone for the prevention of COVID-19 infections among frontline healthcare workers: the HydrOxychloroquine Prophylaxis Evaluation(HOPE) trial: A structured summary of a study protocol for a randomized controlled trial
por: Tirupakuzhi Vijayaraghavan, Bharath Kumar, et al.
Publicado: (2020)

Statistical analysis plan for the BLING III study: a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis
por: Billot, Laurent, et al.
Publicado: (2023)

Efficacy of corticosteroids on survival in patients with sepsis and septic shock: meta-analysis
por: Uchiyama, N, et al.
Publicado: (2009)

Continuous administration of corticosteroids in septic shock can reduce risk of hypernatremia
por: Mirea, L, et al.
Publicado: (2014)

Corticosteroids and Pediatric Septic Shock Outcomes: A Risk Stratified Analysis
por: Atkinson, Sarah J., et al.
Publicado: (2014)

When and how to use predictive biomarkers for corticosteroid treatment of septic shock
por: Russell, James A.
Publicado: (2018)

Corticosteroids in septic shock: a systematic review and network meta-analysis
por: Gibbison, Ben, et al.
Publicado: (2017)

The Role of Adjunctive Therapies in Septic Shock by Gram Negative MDR/XDR Infections
por: Busani, Stefano, et al.
Publicado: (2017)

Time-course evaluation of blood glucose changes in response to insulin delivery in critically ill patients
por: Bass, F, et al.
Publicado: (2014)

Changes in blood glucose concentrations over time when administering intravenous insulin in post cardiac surgery in adult intensive care patients
por: Bass, F, et al.
Publicado: (2015)

Are Corticosteroids Beneficial for Sepsis and Septic Shock? Based on Pooling Analysis of 16 Studies
por: Yao, Yang-Yang, et al.
Publicado: (2019)

Assessment of Machine Learning to Estimate the Individual Treatment Effect of Corticosteroids in Septic Shock
por: Pirracchio, Romain, et al.
Publicado: (2020)

Adjunctive Vasopressors in Patients with Septic Shock: Protocol for a Systematic Review and Meta-Analysis
por: Bauer, Seth R., et al.
Publicado: (2023)

Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial
por: Ibarra-Estrada, Miguel, et al.
Publicado: (2023)

The International Sepsis Forum's controversies in sepsis: corticosteroids should be used to treat septic shock
por: Goodman, Sergey, et al.
Publicado: (2002)

Design and conduct of the activated protein C and corticosteroids for human septic shock (APROCCHSS) trial
por: Annane, Djillali, et al.
Publicado: (2016)

Reevaluating the Role of Corticosteroids in Septic Shock: An Updated Meta-Analysis of Randomized Controlled Trials
por: Lian, X.-J., et al.
Publicado: (2019)

1459 Adjunctive Corticosteroid Therapy in the Treatment of Coccidioidal Meningitis
por: Thompson, George, et al.
Publicado: (2014)

The therapeutic efficacy of adjunct therapeutic plasma exchange for septic shock with multiple organ failure: a single-center experience
por: Keith, Philip D., et al.
Publicado: (2020)

Methylene blue as adjunctive therapy in septic shock: correct drug diluent derives optimal efficacy
por: Dubey, Dilip, et al.
Publicado: (2023)

The International Sepsis Forum's controversies in sepsis: corticosteroids should not be routinely used to treat septic shock
por: Bernard, Gordon
Publicado: (2002)

Evaluation of function of pituitary gland in patients with septic shock and the effect of low-dose corticosteroid therapy
por: Hayami, H, et al.
Publicado: (2006)

Acute effect of low-dose corticosteroids on muscle function in patients with severe sepsis and septic shock
por: Borges, RC, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_orv5tofkf8n36q80nmporsq3n6